Stock Price
2024-10-29
Market Capitalization
2024-08-26
Revenue
FY, 2023
Phase II Trials Products (Oncology)
FY, 2021
Phase III/Filed Trials Products (Oncology)
FY, 2021
Phase I Trials Products (Rare Blood Disorders)
FY, 2020
France
54 Rue la Boétie
United States
55 Corporate Drive
Algeria
29, 30, 31 Micro Zone d’activités Batiment B
Australia
Building D, 12-24 Talavera Road
Austria
Turm A, 29. OG Wienerbergstraße 11
Bangladesh
6/2 Segun Bagicha Rd